Literature DB >> 17674315

Morphine inhibits intrahepatic interferon- alpha expression and enhances complete hepatitis C virus replication.

Yuan Li1, Li Ye, Jin-Song Peng, Chuan-Qing Wang, Guang-Xiang Luo, Ting Zhang, Qi Wan, Wen-Zhe Ho.   

Abstract

Heroin addicts are a high-risk group for hepatitis C virus (HCV) infection and the development of chronic HCV disease. We thus examined whether morphine, the active metabolite of heroin, has the ability to inhibit intrahepatic interferon (IFN)- alpha expression, facilitating HCV replication in human hepatocytes. Morphine inhibited intrahepatic IFN- alpha expression, which was associated with an increase in HCV replication in hepatocytes. Moreover, morphine compromised the anti-HCV effect of recombinant IFN- alpha . Investigation of the mechanism responsible for the morphine action revealed that morphine inhibited expression of IFN regulatory factor 5 in the hepatocytes. In addition, morphine suppressed the expression of p38, an important signal-transducing molecule involved in IFN- alpha -mediated anti-HCV activity. These findings indicate that morphine plays a cofactor role in facilitating HCV persistence in human hepatocytes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17674315     DOI: 10.1086/520093

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  18 in total

1.  Characteristics of chronic hepatitis C among intravenous drug users: a comparative analysis.

Authors:  Maja Jovanović; Branislav Jovanović; Milena Potić; Ljiljana Konstantinović; Miodrag Vrbić; Biljana Radovanović-Dinić; Velimir Kostić
Journal:  Bosn J Basic Med Sci       Date:  2010-05       Impact factor: 3.363

Review 2.  Opioids and HIV/HCV infection.

Authors:  Xu Wang; Ting Zhang; Wen-Zhe Ho
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-14       Impact factor: 4.147

3.  Cyclosporin A inhibits hepatitis C virus replication and restores interferon-alpha expression in hepatocytes.

Authors:  J-P Liu; L Ye; X Wang; J-L Li; W-Z Ho
Journal:  Transpl Infect Dis       Date:  2010-10-07       Impact factor: 2.228

4.  HIV-1 coinfection and morphine coexposure severely dysregulate hepatitis C virus-induced hepatic proinflammatory cytokine release and free radical production: increased pathogenesis coincides with uncoordinated host defenses.

Authors:  Nazira El-Hage; Seth M Dever; Sylvia Fitting; Tasrif Ahmed; Kurt F Hauser
Journal:  J Virol       Date:  2011-09-07       Impact factor: 5.103

Review 5.  Do opioids activate latent HIV-1 by down-regulating anti-HIV microRNAs?

Authors:  Vishnudutt Purohit; Rao S Rapaka; Joni Rutter; David Shurtleff
Journal:  J Neuroimmune Pharmacol       Date:  2012-04-17       Impact factor: 4.147

Review 6.  Synthetic Opioid Use and Common Injection-associated Viruses: Expanding the Translational Research Agenda.

Authors:  Jason T Blackard; Jennifer L Brown; Michael S Lyons
Journal:  Curr HIV Res       Date:  2019       Impact factor: 1.581

7.  Morphine suppresses intracellular interferon-alpha expression in neuronal cells.

Authors:  Qi Wan; Xu Wang; Yan-Jian Wang; Li Song; Shi-Hong Wang; Wen-Zhe Ho
Journal:  J Neuroimmunol       Date:  2008-06-17       Impact factor: 3.478

Review 8.  Intensive Care Unit-acquired infection as a side effect of sedation.

Authors:  Saad Nseir; Demosthenes Makris; Daniel Mathieu; Alain Durocher; Charles-Hugo Marquette
Journal:  Crit Care       Date:  2010-03-15       Impact factor: 9.097

9.  Upregulation of SOCS-3 and PIAS-3 impairs IL-12-mediated interferon-gamma response in CD56 T cells in HCV-infected heroin users.

Authors:  Li Ye; Xu Wang; David S Metzger; Eric Riedel; Luis J Montaner; Wenzhe Ho
Journal:  PLoS One       Date:  2010-03-09       Impact factor: 3.240

Review 10.  Molecular and contextual markers of hepatitis C virus and drug abuse.

Authors:  Paul Shapshak; Charurut Somboonwit; Lydia N Drumright; Simon D W Frost; Deborah Commins; Timothy L Tellinghuisen; William K Scott; Robert Duncan; Clyde McCoy; J Bryan Page; Brian Giunta; Francisco Fernandez; Elyse Singer; Andrew Levine; Alireza Minagar; Oluwadayo Oluwadara; Taiwo Kotila; Francesco Chiappelli; John T Sinnott
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.